Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ALGANEX
L'Aquila, L'Aquila, Italy
- Ownership
- Private
- Development stage
- Other
01
Overview
Alganex is an Italian biotechnology company focused on the discovery and development of innovative small molecule therapeutics for the treatment of chronic and neuropathic pain. The company's research centers on the modulation of the CXCR1/2 chemokine receptors, which play a critical role in the inflammatory processes associated with nerve injury and persistent pain states. By targeting these specific pathways, Alganex aims to provide more effective and safer alternatives to current analgesics, such as opioids and NSAIDs. The company operates as a spin-off from Dompé Farmaceutici and leverages deep expertise in chemokine biology to advance its proprietary pipeline.
- Therapeutic areas
- ImmunologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Dompé Farmaceutici
Beyond the preview
Go deeper on ALGANEX.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ALGANEX.